266 related articles for article (PubMed ID: 37440936)
1. Immunosuppression Monitoring-What Clinician Needs to Know?
Wadhawan M; Gupta C
J Clin Exp Hepatol; 2023; 13(4):691-697. PubMed ID: 37440936
[TBL] [Abstract][Full Text] [Related]
2.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
Höcker B; Tönshoff B
Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
[TBL] [Abstract][Full Text] [Related]
4. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
7. Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial.
Bestard O; Meneghini M; Crespo E; Bemelman F; Koch M; Volk HD; Viklicky O; Giral M; Banas B; Ruiz JC; Melilli E; Hu L; van Duivenvoorden R; Nashan B; Thaiss F; Otto NM; Bold G; Stein M; Sefrin A; Lachmann N; Hruba P; Stranavova L; Brouard S; Braudeau C; Blancho G; Banas M; Irure J; Christakoudi S; Sanchez-Fueyo A; Wood KJ; Reinke P; Grinyó JM
Am J Transplant; 2021 Aug; 21(8):2833-2845. PubMed ID: 33725408
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
9. Immunotolerance in liver transplantation: a primer for the clinician.
Pérez-Escobar J; Jimenez JV; Rodríguez-Aguilar EF; Servín-Rojas M; Ruiz-Manriquez J; Safar-Boueri L; Carrillo-Maravilla E; Navasa M; García-Juárez I
Ann Hepatol; 2023; 28(1):100760. PubMed ID: 36179797
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy post-transplantation in children: what the clinician needs to know.
Tönshoff B
Expert Rev Clin Immunol; 2020 Feb; 16(2):139-154. PubMed ID: 31952458
[No Abstract] [Full Text] [Related]
11. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow augmentation in kidney transplantation: a large animal study.
Gruessner RW; Zhang KY; Dunning M; Nakhleh RE; Gruessner AC
Transpl Int; 2001 Jun; 14(3):159-69. PubMed ID: 11499905
[TBL] [Abstract][Full Text] [Related]
13. The need for minimization strategies: current problems of immunosuppression.
Bamoulid J; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K
Transpl Int; 2015 Aug; 28(8):891-900. PubMed ID: 25752992
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the characteristics of adult liver transplant recipients with prope (almost) tolerance and full immunosuppression regimen.
Shamsaeefar A; Nikoupour H; Kazemi K; Gholami S; Moosavi SA; Motazedian N; Sayadi M; Afshinnia F; Nikeghbalian S; Malekhosseini SA
Transpl Immunol; 2021 Oct; 68():101440. PubMed ID: 34343659
[TBL] [Abstract][Full Text] [Related]
15. Weaning of immunosuppression in liver transplant recipients.
Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
[TBL] [Abstract][Full Text] [Related]
16. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
Krisl A; Stampf S; Hauri D; Binet I; Mueller T; Sidler D; Hadaya K; Golshayan D; Pascual M; Koller M; Dickenmann M; The Swiss Transplant Cohort Study Stcs
Swiss Med Wkly; 2020 Nov; 150():w20354. PubMed ID: 33277913
[TBL] [Abstract][Full Text] [Related]
18. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G;
Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445
[TBL] [Abstract][Full Text] [Related]
19. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.
Yao G; Albon E; Adi Y; Milford D; Bayliss S; Ready A; Raftery J; Taylor RS
Health Technol Assess; 2006 Dec; 10(49):iii-iv, ix-xi, 1-157. PubMed ID: 17134597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
